CDC Advisory Committee discuss rare side effect possibly linked to Johnson & Johnson COVID-19 vaccine

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, met on Thursday to review data on the need for COVID-19 booster shots, and also discuss newly discovered safety concerns about Johnson & Johnson’s COVID-19 vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting